GlaxoSmithKline plc Company Profile (LON:GSK)

About GlaxoSmithKline plc

GlaxoSmithKline plc logoGlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company's segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals business develops and makes medicines to treat a range of acute and chronic diseases. The Vaccines business develops, produces and distributes over 1.9 million vaccines every day to people across the world. The Consumer Healthcare business develops and markets products in various categories, such as Wellness, Oral health, Nutrition and Skin health. The Pharmaceuticals Research and Development (R&D) focuses on the discovery and development in various areas of research, which include human immunodeficiency virus (HIV) and infectious diseases, oncology, immuno-inflammation, respiratory and rare diseases.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: GSK
  • CUSIP:
Key Metrics:
  • Previous Close: $21.67
  • 50 Day Moving Average: $1671.01
  • 200 Day Moving Average: $1499.81
  • Trailing P/E Ratio: 2749.17
  • P/E Growth: 1.26
  • Market Cap: $80.18B
  • Outstanding Shares: 4,861,000,000
Additional Links:

Analyst Ratings

Consensus Ratings for GlaxoSmithKline plc (LON:GSK) (?)
Ratings Breakdown: 2 Sell Ratings, 19 Hold Ratings, 7 Buy Ratings
Consensus Rating:Hold (Score: 2.18)
Consensus Price Target: GBX 1,651.04

Analysts' Ratings History for GlaxoSmithKline plc (LON:GSK)
DateFirmActionRatingPrice TargetDetails
8/23/2016JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,900View Rating Details
8/17/2016Shore CapitalReiterated RatingHoldView Rating Details
8/9/2016Berenberg BankSet Price TargetNeutralGBX 1,885View Rating Details
8/4/2016Independent Research GmbHSet Price TargetNeutralGBX 1,800View Rating Details
8/4/2016BNP ParibasReiterated RatingNeutralGBX 1,560View Rating Details
8/4/2016Jefferies GroupReiterated RatingBuyGBX 2,000View Rating Details
8/2/2016Beaufort SecuritiesReiterated RatingBuyView Rating Details
7/28/2016Sanford C. BernsteinSet Price TargetNeutralGBX 1,755View Rating Details
7/28/2016Bryan, Garnier & CoReiterated RatingBuyView Rating Details
7/28/2016Deutsche Bank AGReiterated RatingHoldGBX 1,700View Rating Details
7/27/2016S&P Global Inc.Set Price TargetNeutralGBX 1,650View Rating Details
7/27/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
7/14/2016Credit Suisse Group AGReiterated RatingNeutralGBX 1,800View Rating Details
7/12/2016Goldman Sachs Group Inc.Reiterated RatingBuyGBX 1,800View Rating Details
7/11/2016Morgan StanleyBoost Price TargetEqual weightGBX 1,500 -> GBX 1,650View Rating Details
7/7/2016Canaccord GenuityReiterated RatingHoldGBX 1,785View Rating Details
5/4/2016Barclays PLCBoost Price TargetOverweightGBX 1,650 -> GBX 1,670View Rating Details
4/28/2016HSBCBoost Price TargetBuyGBX 1,800 -> GBX 1,865View Rating Details
4/28/2016Societe GeneraleReiterated RatingSellGBX 1,300View Rating Details
4/14/2016Liberum CapitalReiterated RatingHoldGBX 1,350View Rating Details
3/10/2016AlphaValueReiterated RatingAddGBX 1,536View Rating Details
2/12/2016Baader BankReiterated RatingHoldGBX 1,530View Rating Details
1/28/2016Leerink SwannReiterated RatingMarket PerformGBX 1,565View Rating Details
1/13/2016NatixisReiterated RatingNeutralGBX 1,470View Rating Details
11/17/2015JP Morgan CazenoveReiterated RatingNeutralGBX 1,370View Rating Details
11/6/2015Oddo SecuritiesReiterated RatingReduceGBX 1,360View Rating Details
10/5/2015Kepler Capital MarketsReiterated RatingHoldGBX 1,540View Rating Details
9/7/2015Bank of America Corp.UpgradeNeutralView Rating Details
6/9/2015Cenkos Securities LtdReiterated RatingBuyGBX 1,643View Rating Details
5/7/2015Charles StanleyReiterated RatingaccumulateView Rating Details
9/19/2014KillikReiterated RatingNeutralView Rating Details
(Data available from 8/26/2014 forward)


Earnings History for GlaxoSmithKline plc (LON:GSK)
No earnings announcements for this company have been tracked by


Earnings Estimates for GlaxoSmithKline plc (LON:GSK)
Current Year EPS Consensus Estimate: $96.53 EPS


Dividend History for GlaxoSmithKline plc (LON:GSK)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/27/2016GBX 191.12%8/11/20168/11/201610/13/2016
4/27/2016GBX 191.28%5/12/20165/12/20167/14/2016
10/28/2015GBX 191.34%11/12/201511/12/20151/14/2016
10/28/2015GBX 201.34%2/18/20162/18/20164/14/2016
7/29/2015GBX 191.38%8/13/20158/13/201510/1/2015
5/6/2015GBX 191.25%5/14/20155/14/20157/9/2015
2/4/2015GBX 231.56%2/19/20152/19/20154/9/2015
10/22/2014GBX 191.37%11/6/201411/6/20141/8/2015
7/23/2014GBX 191.28%8/6/20148/6/201410/2/2014
4/30/2014GBX 191.17%5/14/20145/14/20147/10/2014
2/5/2014GBX 231.36%2/19/20142/19/20144/10/2014
10/23/2013GBX 191.15%11/13/201311/13/20131/9/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for GlaxoSmithKline plc (LON:GSK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/12/2016Slaoui,MoncefInsiderBuy28GBX 2,208£618.24
8/9/2016Dingemans,SimonInsiderBuy8GBX 1,680£134.40
7/27/2016Witty,Sir Andrew PInsiderSell10,000GBX 1,693£169,300
7/11/2016Witty,Sir Andrew PInsiderBuy7GBX 1,671£116.97
7/8/2016Slaoui,MoncefInsiderBuy4GBX 2,169GBX 8,676
7/1/2016Cartwright,StaceyInsiderBuy461GBX 1,559£7,186.99
6/9/2016Dingemans,SimonInsiderBuy9GBX 1,441£129.69
5/20/2016Slaoui,MoncefInsiderBuy14GBX 2,100£294
5/12/2016Slaoui,MoncefInsiderBuy24GBX 2,103£504.72
5/11/2016Witty,Sir Andrew PInsiderBuy8GBX 1,476£118.08
4/28/2016Witty,Sir Andrew PInsiderSell10,000GBX 1,475£147,500
4/14/2016Slaoui,MoncefInsiderBuy495GBX 2,156£10,672.20
3/31/2016Anderson,Sir RoyInsiderBuy511GBX 1,405£7,179.55
3/9/2016Witty,Sir Andrew PInsiderBuy9GBX 1,404£126.36
2/15/2016Dingemans,SimonInsiderSell39,987GBX 1,406£562,217.22
2/9/2016Witty,Sir Andrew PInsiderBuy9GBX 1,369£123.21
1/28/2016Dingemans,SimonInsiderBuy684GBX 1,381£9,446.04
1/14/2016Witty,Sir Andrew PInsiderBuy43GBX 1,369£588.67
1/12/2016Dingemans,SimonInsiderBuy9GBX 1,359£122.31
12/9/2015Dingemans,SimonInsiderBuy9GBX 1,325£119.25
11/10/2015Dingemans,SimonInsiderBuy9GBX 1,366£122.94
10/12/2015Dingemans,SimonInsiderBuy10GBX 1,307£130.70
10/1/2015Rohner,UrsInsiderBuy525GBX 1,251£6,567.75
9/10/2015Witty,Sir Andrew PInsiderBuy10GBX 1,318£131.80
8/12/2015Dingemans,SimonInsiderBuy8GBX 1,443£115.44
7/10/2015Witty,Sir Andrew PInsiderBuy9GBX 1,369£123.21
7/1/2015Wijers,HansInsiderBuy534GBX 13.45GBX 7,182.30
3/31/2015Sir Christopher GentInsiderBuy3,991GBX 1,566£62,499.06
3/9/2015Moncef SlaouiInsiderSell22,274GBX 1,544£343,910.56
2/18/2015Moncef SlaouiInsiderSell1,580GBX 1,553£24,537.40
2/13/2015Simon DingemansInsiderSell12,605GBX 1,543.12£194,510.28
(Data available from 1/1/2013 forward)


Latest Headlines for GlaxoSmithKline plc (LON:GSK)
News IconHC Stocks Newsbeat: GlaxoSmithKline plc (ADR) (GSK), ACADIA Pharmaceuticals Inc. (ACAD) - share market updates (press release) (LON:GSK) - August 25 at 10:20 AM logoETF’s with exposure to GlaxoSmithKline Plc : August 24, 2016 (LON:GSK) - August 24 at 5:12 PM
News IconGlaxoSmithKline plc (NYSE:GSK) Upcoming Earnings: What matter for investors? - The Voice Registrar (LON:GSK) - August 23 at 5:28 PM logoGlaxoSmithKline Plc :GSK-GB: Earnings Analysis: Q2, 2016 By the Numbers : August 23, 2016 (LON:GSK) - August 23 at 9:42 AM logo[$$] US doctors waste millions on branded medicines (LON:GSK) - August 21 at 4:52 PM
News IconDrug Manufacturers – Major: GlaxoSmithKline plc (NYSE:GSK) Position of the day (LON:GSK) - August 19 at 5:18 PM
News IconEconomic Crunch Hit Nigeria’s Healthcare Sector As Quoted Profits Dips (LON:GSK) - August 16 at 8:40 AM logoGLAXOSMITHKLINE : ViiV Healthcare launches phase III programme evaluating a two-drug regimen combining dolutegravir and lamivudine for HIV-1 treatment (LON:GSK) - August 16 at 8:40 AM logoViiV starts PhIII Programme for dolutegravir & 3TC (LON:GSK) - August 16 at 8:40 AM logoViiV Healthcare launches phase III programme evaluating a two-drug regimen combining dolutegravir and lamivudine for HIV-1 treatment (LON:GSK) - August 16 at 8:40 AM logo[$$] Yield to temptation as bond incomes fall (LON:GSK) - August 11 at 5:33 PM
News IconHC Stocks in Top Row: GlaxoSmithKline plc (ADR) (GSK), Horizon Pharma PLC (HZNP) - share market updates (press release) (LON:GSK) - August 10 at 12:46 PM logoGlaxoSmithKline Plc (NYSE:GSK) To Offer Warranty On Strimvelis For Bubble Boy Disease - Market Exclusive (LON:GSK) - August 10 at 12:46 PM
News IconGSK Nigeria sells N23b drink business this month (LON:GSK) - August 9 at 9:40 PM logoAre GlaxoSmithKline plc and GW Pharmaceuticals plc simply too expensive? (LON:GSK) - August 9 at 4:06 PM logoGlaxoSmithKline's Dividend Health (LON:GSK) - August 9 at 4:06 PM
News IconHC Stocks Buzzer: GlaxoSmithKline plc (ADR) (NYSE:GSK), Opko Health Inc. (NYSE:OPK) - share market updates (press release) (LON:GSK) - August 9 at 8:16 AM logoAnalysis - Future of drug pricing: paying for benefits not per pill (LON:GSK) - August 9 at 8:16 AM logoOverview of Analysts Suggestions: Teva Pharmaceutical Industries ... - Street Updates (LON:GSK) - August 8 at 5:30 PM
News IconToday's Top Gainers in the Market GlaxoSmithKline plc (NYSE:GSK ... - The Daily Leicester (LON:GSK) - August 6 at 8:12 AM logoNoteworthy Analysts Suggestions: Horizon Pharma plc (NASDAQ:HZNP) , GlaxoSmithKline PLC (NYSE:GSK) - Street Updates (LON:GSK) - August 3 at 5:39 PM logoRevenue Update on GlaxoSmithKline plc (ADR)(NYSE:GSK) - Trade Calls (LON:GSK) - August 3 at 5:39 PM logoAlphabet and Glaxo Team Up to Jumpstart Your Profits (LON:GSK) - August 2 at 5:35 PM logoGlaxoSmithKline plc (ADR)(GSK) and Alphabet Inc (GOOGL) Team Up for Joint Venture - TCC (LON:GSK) - August 1 at 5:13 PM logoA statement released earlier today by Jefferies International about (LON:GSK) GlaxoSmithKline PLC holds the target price at 2,000GBX (LON:GSK) - August 1 at 10:03 AM logoGlaxoSmithKline and Alphabet Partner to Start Bioelectronics Company (GSK, GOOG) (LON:GSK) - August 1 at 10:03 AM logo$715M joint venture: GlaxoSmithKline, former Google life sciences unit, form tech partnership (LON:GSK) - August 1 at 10:03 AM logoGlaxosmithKline teams up with Google sister firm in bioelectronics venture (LON:GSK) - August 1 at 10:03 AM logoNotable Analysts Assessment of Stocks: GlaxoSmithKline PLC (NYSE:GSK) , Globus Medical, Inc. (NYSE:GMED) - Street Updates (LON:GSK) - July 29 at 5:28 PM logoBRIEF-Glaxosmithkline Consumer Nigeria reports HY pre-tax profit of 424.8 mln naira (LON:GSK) - July 29 at 12:28 PM logoSouth African pharmaceutical firms say strike causing "very little" disruption (LON:GSK) - July 29 at 6:28 AM logoSouth African pharmaceutical workers launch pay strike (LON:GSK) - July 29 at 4:09 AM logo[$$] Cutting rates would be madhouse economics for the Bank of England (LON:GSK) - July 29 at 2:35 AM logoDeutsche Bank recorded (LON:GSK) GlaxoSmithKline PLC, renewing its price target at 1700GBX earlier today - Breaking Finance News (LON:GSK) - July 28 at 4:07 PM logoGlaxoSmithKline plc (NYSE:GSK) To Invest $360 Million In Britain Amid Brexit Concerns - Market Exclusive (LON:GSK) - July 28 at 4:07 PM logoMcDonald’s Joins Glaxo in Giving Jobs Boost to Post-Brexit U.K. (LON:GSK) - July 27 at 5:33 PM logoShould you buy GlaxoSmithKline plc after today’s results? (LON:GSK) - July 27 at 5:33 PM logoGlaxo Swings to Loss on Write-down (LON:GSK) - July 27 at 5:33 PM logo[$$] Glaxo Swings to Loss (LON:GSK) - July 27 at 7:50 AM logoGSK in-licenses anti-IL-33R monoclonal antibody for severe asthma from Janssen (LON:GSK) - July 27 at 7:48 AM logoShould You Buy GlaxoSmithKline After Today's Brilliant Results? (LON:GSK) - July 27 at 7:44 AM logoGSK Plans £275m UK Investment After EU Vote (LON:GSK) - July 27 at 7:35 AM logoGSK results ride sterling's roller-coaster (LON:GSK) - July 27 at 7:25 AM logoGSK outlook brightens as Brexit brings currency windfall (LON:GSK) - July 27 at 7:20 AM logoGSK chases next biotech asthma drug with 175 million pounds J&J deal (LON:GSK) - July 27 at 7:20 AM logoGlaxoSmithKline invests 275 million pounds in UK despite Brexit vote (LON:GSK) - July 27 at 7:20 AM logoResults Announcement for the second quarter 2016 and Half-yearly Financial Report for the half-year 2016 (LON:GSK) - July 27 at 7:18 AM logoAnalysts Tips to Monitor: Merck & Company, Inc. (NYSE:MRK) , GlaxoSmithKline PLC (NYSE:GSK) - Street Updates (LON:GSK) - July 25 at 9:56 AM
News IconHC Stocks Judgment: GlaxoSmithKline plc (ADR) (NYSE:GSK) Perrigo Company plc Ordinary Shares (NYSE:PRGO) - share market updates (press release) (LON:GSK) - July 25 at 9:56 AM
News IconToday's Top Gainers in the Market GlaxoSmithKline plc (NYSE:GSK) from Healthcare - The Daily Leicester (LON:GSK) - July 22 at 5:16 PM


Last Updated on 8/26/2016 by Staff